These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8103100

  • 21. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H, Murata S, Yabana H, Kikkawa K, Sugawara Y, Akimoto Y, Nagao T.
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [Abstract] [Full Text] [Related]

  • 22. SD-3211, a novel benzothiazine calcium antagonist, alone and in combination with a beta-adrenoceptor antagonist, produces antihypertensive effects without affecting heart rate and atrioventricular conduction in conscious renal hypertensive dogs.
    Kageyama M, Nishimura K, Takada T, Miyawaki N, Yamauchi H.
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):102-7. PubMed ID: 1708042
    [Abstract] [Full Text] [Related]

  • 23. Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats.
    Fujiwara K, Kanno Y, Hayashi K, Takenaka T, Saruta T.
    Clin Exp Hypertens; 1998 Apr; 20(3):295-312. PubMed ID: 9605384
    [Abstract] [Full Text] [Related]

  • 24. Antihypertensive effect of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride in rats.
    Wada K, Nakamura S, Morishita S, Kanda M, Matsui H, Fukata F, Shirahase H.
    Arzneimittelforschung; 1994 Oct; 44(10):1112-6. PubMed ID: 7818582
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
    Mervaala EM, Malmberg L, Teräväinen TL, Laakso J, Vapaatalo H, Karppanen H.
    Br J Pharmacol; 1998 Jan; 123(2):195-204. PubMed ID: 9489606
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antihypertensive effect of CV-4093.2HCl, a new calcium antagonist, in three rat models of hypertension.
    Kakihana M, Suno M, Nagaoka A.
    Jpn J Pharmacol; 1988 Oct; 48(2):223-8. PubMed ID: 3210447
    [Abstract] [Full Text] [Related]

  • 32. Effects of the new angiotensin II type 1 receptor antagonist KRH-594 on several types of experimental hypertension.
    Inada Y, Murakami M, Kaido K, Nakao K.
    Arzneimittelforschung; 1999 Jan; 49(1):13-21. PubMed ID: 10028373
    [Abstract] [Full Text] [Related]

  • 33. Antihypertensive effects of AJ-2615, a new calcium antagonist with alpha 1-adrenergic blocking activity in experimental hypertensive animals.
    Ikeno A, Nose I, Fukuya F, Minato H, Takeyama K, Hosoki K, Karasawa T.
    J Cardiovasc Pharmacol; 1993 May; 21(5):815-21. PubMed ID: 7685454
    [Abstract] [Full Text] [Related]

  • 34. [Effect of efonidipine hydrochloride (NZ-105), a new dihydropyridine calcium antagonist, on the experimental atherosclerosis in cholesterol-fed rabbits].
    Toyoda K, Kitahara M, Yamashita T, Shudo C, Masuda Y, Sakashita M, Tanaka S, Saito Y.
    Nihon Yakurigaku Zasshi; 1994 May; 103(5):231-9. PubMed ID: 8188119
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Hypotensive effects of YM430, a 1,4-dihydropyridine derivative, in spontaneously hypertensive rats and renal hypertensive dogs.
    Shibasaki K, Takizawa K, Uchida W, Takenaka T.
    Jpn J Pharmacol; 1997 Feb; 73(2):113-24. PubMed ID: 9074945
    [Abstract] [Full Text] [Related]

  • 38. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M, Passoni A, Casciarri I, Bosetti P, Piazzoni L, Cazzulani P, Gandolfi CA, Tofanetti O, Ceserani R.
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [Abstract] [Full Text] [Related]

  • 39. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
    Harada K, Nomura M, Nishikado A, Uehara K, Nakaya Y, Ito S.
    Circ J; 2003 Feb; 67(2):139-45. PubMed ID: 12547996
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.